Fornaro M, Prestia D, Colicchio S, Perugi G (2010) A systematic, updated review on the antide-

pressant agomelatine focusing to its melatoninergic modulation. Curr Neuropharmacol 8:287–

304

Freiesleben SD, Furczyk K (2015) A systematic review of agomelatine-induced liver injury. J Mol

Psychiatry 3:4. https://doi.org/10.1186/s40303-015-0011-7

Gareri P, Segura-Garcia C, Manfredi VGL, Bruni A, Ciambrione P, Cerminara G, De Sarro G, De

Fazio P (2014) Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging

9:1363–1373

Gärtner R, Cronin-Fenton D, Hundborg HH, Pedersen L, Lash TL, Sorensen HT, Kroman N (2010)

Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical

bleeding in breast cancer patients: a Danish population-based cohort study. BMC Surg 10:3.

http://www.biomedcentral.com/1471-2482/10/3

Ghose K, Spragg BP (1989) Pharmacokinetics of lofepramine and amitriprtyline in elderly healthy

subjects. Int Clin Psychopharmacol 4(3):201–215

Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ (2012) Benefits from antidepressants:

synthesis of 6-week patient-level outcomes from double-blind placebo controlled randomized

trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 69(6):572–579

Gjestad C, Westin AA, Skogvoll E, Spigset O (2015) Effect of proton pump inhibitors on the serum

concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and

sertraline. Ther Drug Monit 37(1):90–97

Glassman AH, Bigger LT Jr, Giardina EV, Kantor SJ, Perel JM, Davies M (1979) Clinical

characteristics of imipramine-induced orthostatic hypotension. Lancet 1(8114):468–472

Goldstein DJ, Hamilton SH, Masica DN, Beasley C Jr (1997) Fluoxetine in medically stable,

depressed geriatric patients: effects on weight. J Clin Psychopharmacol 17(5):365–369

Gram LF, Sondergaard I, Christiansen J, Petersen GO, Bech P, Reisby N, Ibsen I, Ortmann J,

Nagy A, Dencker SJ, Jacobsen O, Krautwald O (1977) Steady-state kinetics of imipramine in

patients. Psychopharmacology 54(3):255–261

Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G, Christensson A (2005) Simple

cystatin C-based prediction equations for glomerular filtration rate compared with the modifica-

tion of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-

Barratt prediction equations for children. Clin Chem 51(8):1420–1431

Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EHF (2004) The selective

norepinephrine reuptake inhibitor antidepressant riboxetine: pharmacological and clinical pro-

file. CNS Drug Rev 10(1):23–44

Hansen MR, Kuhlmann IB, Pottegard A, Damkier P (2017) Therapeutic drug monitoring of

venlafaxine in an everyday clinical setting: analysis of age, sex and dose concentration relation-

ship. Basic Clin Pharmacol Toxicol 121:298–312

Harvey AT, Preskorn SH (2001) Fluoxetine pharmacokinetics and effect on CYP2C19 in young

and elderly volunteers. J Clin Pharm Ther 21(2):161–166

He J, Fang P, Zheng X, Wang C, Liu T, Zhang B, Wen J, Xu R (2018) Inhibitory effect of celecoxib

on agomelatine metabolism in vitro and in vivo. Drug Des Devel Ther 12:513–519

He Q, Hou Q, Wang Y, Shen L, Sun Z, Zhang H, Liong M-T, Kwok L-Y (2020) Long-term

administration of Lactobacillus casei Zhang stabilized gut microbiota of adults and reduced

microbiota age index in older adults. J Funct Foods 64(103682):1–11. https://doi.org/10.1016/j.

jff.2019.103682

Hedna K, Hakkarainen KM, Gyllensten H, Jönsson AK, Petzold M, Hägg S (2015) Potentially

inappropriate prescribing and adverse drug reactions in the elderly: a population-based study.

Eur J Clin Pharmacol 71:1525–1533

Hefner G, Hahn M, Hohner M, Roll SC, Klimke A, Hiemke C (2019) QTc time correlates with

amitriptyline and venlafaxine serum levels in elderly psychiatric inpatients. Pharmacopsychiatry

52(1):38–43

Henry JF, Altamura C, Gomeni R, Hervy MP, Florette F, Morselli PL (1981) Pharmacokinetics of

amitriptyline in the elderly. Int J Clin Pharmacol Ther Toxicol 19(1):1–5

15

The Importance of Drug Dose Adjustment in Elderly Patients with Special. . .

267